What changed in this filing

/stocks — the workspaceLOADING

Item 5. Market for Registrant’s Common Equity

2026-03-27 compared with 2025-03-25 · 32 added, 32 removed, 17 unchanged (79% of the section changed)

Market for Registrant’s Common Equity, Related Stockholder Matters, and Issuer Purchases of Equity Securities.

Market for Registrant’s Common

Equity, Related Stockholder Matters, and Issuer Purchases of Equity Securities.

Market Information

Our Units, Public Shares and

5 unchanged sentences

holder of record of our Class A Ordinary Shares, one holder of record of our Class B Ordinary Shares, and three holders of record of our

We have not paid any cash

6 unchanged sentences

is not currently contemplating and does not anticipate declaring any share dividends in the foreseeable future.

Further, if we incur

any indebtedness in connection with our initial Business Combination, our ability to declare dividends may be limited by restrictive

covenants we may agree to in connection therewith.

(d) Securities

Authorized for Issuance Under Equity Compensation Plans

(e) Performance

Further, if we incur any

indebtedness in connection with our initial Business Combination, our ability to declare dividends may be limited by restrictive covenants

we may agree to in connection therewith.

Securities Authorized for Issuance Under Equity Compensation Plans

Performance Graph

As a smaller reporting company,

we are not required to provide the information required by Regulation S-K Item 201(e).

Sales of Unregistered Securities

Simultaneously with the closing of the Initial Public Offering and

pursuant to the Private Placement Warrants Purchase Agreements, we completed the sale of an aggregate of 7,075,000 Private Placement Warrants

to the Sponsor and Cantor in the Private Placement at a purchase price of $1.00 per Private Placement Warrant, generating gross proceeds

to us of $ 7,075,000.

Of those 7,075,000 Private Placement Warrants, the Sponsor purchased 4,500,000 Private Placement Warrants and Cantor

purchased 2,575,000 Private Placement Warrants.

The Private Placement Warrants are identical to the Public Warrants sold in the Initial

Public Offering, except as otherwise disclosed in the IPO Registration Statement.

No underwriting discounts or commissions were paid with

respect to such sale.

The issuance of the Private Placement Warrants was made pursuant to the exemption from registration contained in

Section 4(a)(2) of the Securities Act.

of Proceeds from the Initial Public Offering

For a description of the use of proceeds generated in our Initial Public

Offering and Private Placement, see Part II, Item 2 of our Quarterly Report on Form 10-Q for the quarterly period ended September 30,

2024, as filed with the SEC on November 19, 2024.

There has been no material change in the planned use of proceeds from our Initial Public

Offering and Private Placement as described in the IPO Registration Statement.

The specific investments in our Trust Account may change

from time to time.

(h) Purchases

of Equity Securities by the Issuer and Affiliated Purchasers

were no such repurchases of our equity securities by us or an affiliate during the fourth quarter of the fiscal year covered by the Report.

Recent Sales of Unregistered Securities

were no sales of unregistered securities during the fiscal year covered by this Report.

However, simultaneously with the closing of the

Initial Public Offering and pursuant to the Private Placement Warrants Purchase Agreements, we completed the sale of an aggregate of 7,075,000

Private Placement Warrants to the Sponsor and Cantor in the Private Placement at a purchase price of $1.00 per Private Placement Warrant,

generating gross proceeds to us of $ 7,075,000.

Of those 7,075,000 Private Placement Warrants, the Sponsor purchased 4,500,000 Private

Placement Warrants and Cantor purchased 2,575,000 Private Placement Warrants.

The Private Placement Warrants are identical to the

Public Warrants sold in the Initial Public Offering, except as otherwise disclosed in the IPO Registration Statement.

No underwriting

discounts or commissions were paid with respect to such sale.

The issuance of the Private Placement Warrants was made pursuant to the

exemption from registration contained in Section 4(a)(2) of the Securities Act.

Use of Proceeds

There were no offerings of

registered securities and therefore no planned use of proceeds from such offerings during the fiscal year covered by this Report.

a description of the use of proceeds generated in our Initial Public Offering and Private Placement, see Part II, Item 2 of our Quarterly

Report on Form 10-Q for the quarterly period ended September 30, 2024, as filed with the SEC on November 19, 2024.

There has been no material

change in the planned use of proceeds from our Initial Public Offering and Private Placement as described in the IPO Registration Statement.

The specific investments in our Trust Account may change from time to time.

Purchases of Equity Securities by the Issuer and Affiliated Purchasers

were no purchases of our equity securities by us or an affiliate during the fourth quarter of the fiscal year covered by the Report.

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.

What changed 10-K

Item 5. Market for Registrant’s Common Equity